Filing search / Iovance Biotherapeutics, Inc. / "Research and Development" / Page 3

8-K

EX-99.1

ry5e9j

24 Feb 22

Iovance Biotherapeutics Reports Fourth Quarter and Full Year 2021

4:06pm

8-K

EX-99.1

vje0ujmf

4 Nov 21

Iovance Biotherapeutics Reports Third Quarter and Year-to-Date 2021

4:06pm

8-K

EX-99.1

eb3zvvq7irn3 kly

5 Aug 21

Iovance Biotherapeutics Reports Second Quarter and First Half 2021

4:05pm

8-K

EX-99.1

zoe juia11f

6 May 21

Iovance Biotherapeutics Reports First Quarter 2021

4:06pm

8-K

EX-99.1

5hto0t03e7ivlc

25 Feb 21

Iovance Biotherapeutics Reports Fourth Quarter and Full Year 2020

4:05pm

424B5

1wz wumu5e52lh

9 Feb 21

Prospectus supplement for primary offering

6:45am

8-K

EX-10.1

9nbsywaqez8adt7 47h

8 Feb 21

Entry into a Material Definitive Agreement

9:55pm

8-K

EX-99.1

v9zoz042fxa0gob3rmka

5 Nov 20

Iovance Biotherapeutics Reports Third Quarter and Year-to-Date 2020

4:05pm

8-K

EX-99.1

51ar17bu2ex34iduzi

5 Oct 20

Investigating the Power of Tumor Infiltrating Lymphocytes for Treatment of Cancer October 2020

5:15pm

8-K

EX-99.2

tt3064p57aezse9

5 Oct 20

Investigating the Power of Tumor Infiltrating Lymphocytes for Treatment of Cancer October 2020

5:15pm